Aigle, Switzerland, July 4th, 2018 – Today, the Cycling Anti-Doping Foundation (CADF), the independent organisation mandated by the Union Cycliste Internationale (UCI) to define and manage the fight against doping in cycling, announced its strategy for the 2018 Tour de France starting on Saturday 7th July, which will be implemented in close cooperation with the Agence Française de Lutte contre le Dopage (AFLD), the National Anti-Doping Organisation of France. MORE
The CADF is delighted to communicate the appointment of Mr. Andy Parkinson as new member of the CADF Foundation Board.
Mr. Andy Parkinson is the Chief Executive Officer of British Rowing, having joined the organisation in this role in January 2015.
An intelligence-led doping test was carried out by the CADF in collaboration with the AFLD (Agence Française de Lutte contre le Dopage) and the OCLAEPS (Office Central de Lutte contre les Atteintes à l‘Environnement et la Santé Publique) on March the 8th 2018 on the French Rider Rémy Di Gregorio during the UCI WorldTour race Paris-Nice. The test returned an Adverse Analytical Finding (AAF) for Darbepoetin (dEPO)*. The rider was provisionally suspended by the UCI (Union Cycliste Internationale) and a press release was published on the UCI website (http://www.uci.ch/pressreleases/uci-statement-remy-gregorio/) * dEPO is classified as “Peptide Hormones, Growth Factors, Related Substances and Mimetics” as per the World Anti-Doping Prohibited List.”
To Riders and Support Personnel The 2018 Prohibited List comes into effect on 1 January 2018. It is highly recommended that all Riders and Support Staff take the time to familiarize themselves with this important information. (Several languages below)
The Cycling Anti-Doping Foundation (CADF) is giving everyone an opportunity to report any doping-related suspicion about athletes, supporting staff or entourage. All e-mails will be treated confidentially. Thank you for your contribution to a clean sport of cycling.